<DOC>
	<DOCNO>NCT02758808</DOCNO>
	<brief_summary>The Pulmonary Fibrosis Foundation Patient Registry collect data least 2,000 patient interstitial lung disease ( ILD ) approximately 40 clinical site US . The Registry target enrollment approximately 60 % 2,000 ILD participant idiopathic pulmonary fibrosis ( IPF ) . The aim Registry create cohort well-characterized patient interstitial lung disease ( ILD ) participation retrospective prospective research</brief_summary>
	<brief_title>Pulmonary Fibrosis Foundation Patient Registry</brief_title>
	<detailed_description>The Pulmonary Fibrosis Foundation Patient Registry collect data least 2,000 patient interstitial lung disease ( ILD ) approximately 40 clinical site US . The Registry target enrollment approximately 60 % 2,000 ILD participant idiopathic pulmonary fibrosis ( IPF ) . The aim Registry create cohort well-characterized patient interstitial lung disease ( ILD ) participation retrospective prospective research . Patients meet inclusion exclusion criterion treat Registry site ask participate . Patients require read sign Institutional review board ( IRB ) -approved informed consent document prior Registry activity take place . At time informed consent , participant ask indicate interested contact Registry site personnel potential participation future clinical trial and/or study . Participants opt contact future study . No clinical procedure , test , diagnostics require virtue Registry participation . Participants permit Registry staff abstract clinical data obtain part routine clinical care diagnosis treatment ILD . These data enter web-based , electronic data capture ( EDC ) Registry staff regular interval . Some data retrospective , collect prior consent Registry . Computed tomography ( CT ) image collect diagnosis / treatment de-identified Registry site uploaded secure server 21 Code Federal Regulations ( CFR ) Part 11 , Good Clinical Practice ( GCP ) , HIPAA compliant online image repository . Participants ask complete patient report outcome ( PRO ) survey relate ILD symptom quality life time enrollment clinical follow-up visits.Participants see clinical follow-up within 12 month contact telephone mail Registry site personnel complete PRO measure . The University Michigan Statistical Analysis Biomedical Educational Research ( SABER ) unit serve Registry Data Coordinating Center manage data enter web base , CFR 21 Part 11 compliant electronic data capture ( EDC ) system Registry sit .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<criteria>1 . 18 year old old 2 . Understand sign inform consent document 3 . ILD Diagnosis must make / confirm participate Registry center . 1 . The diagnostic evaluation must include , minimum , medical history , physical examination , pulmonary function test computerized tomography ( CT ) scan chest . 2 . If patient exhibit another pulmonary disease ( emphysema asthma ) , primary disease must ILD . 4 . Anticipated additional follow Registry center within one year . 1 . Diagnosed : 1 . Sarcoid 2 . Lymphangioleiomyomatosis ( LAM ) 3 . Pulmonary alveolar proteinosis ( PAP ) 4 . Cystic fibrosis ( CF ) 5 . Amyloidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>